Skip to content

OSTX - OS Therapies Inc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchO

OS Therapies Incorporated

OSTX · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

O

OSTXOS Therapies Incorporated

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.57
52-wk low: $1.15
Prev close: $1.96
Mkt cap: $67.3M
Fwd P/E: 1.7x
Beta: -0.73

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$981K

MW
Marshall Wace
Q2 2026 13F
$191K
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 14, 2026

Earnings came in 20.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 1.66
Market cap: $67M

Valuation

P/B13.65

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: OSTX
Exchange: AMEX
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $67.34M
Beta: -0.73

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

13.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-914.0%

$58K

position

MI

Millennium

Israel Englander · Q4 2025 13F

$43K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for OSTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.20+20.0%

-$0.25 expected

Next report

What the street expects next

EPS expected

-$0.24

-$0.29 to -$0.19

Revenue expected

$750.0K

4 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.04

Change in 30 days

-914.0%

ROA-366.6%

Growth

Beta-0.73